ArticleProceedings (Baylor University. Medical Center)
The burden of digestive diseases in Jordan: a longitudinal analysis of Global Burden of Disease Study, 1990-2021.
Article in Proceedings (Baylor University. Medical Center). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- It's a small world after all.Proceedings (Baylor University. Medical Center)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the last decade, the estimated prevalence of metabolic-associated fatty liver disease (MAFLD) in the Middle East and North African population has been gradually increasing and was recently found to exceed 40%, indicating an alarming trend. The morbidly and mortality attributed to digestive disease in Jordanian people has not been thoroughly investigated, and the relevant data are restricted to sporadic reports from cross-sectional studies, which are likely underestimated. This study aimed to identify the epidemiological trends and risk factors of digestive diseases in Jordan from 1990 to 2021. Methods: The study utilized the 2019 Global Burden of Disease study dataset, which includes estimates for incidence, prevalence, and disability-adjusted life-years (DALYs), years lived with short-term or long-term health loss, and years of life lost due to premature death for digestive disorders. Trends were analyzed using percentage change calculations. Results: Between 1990 and 2021, the all-age prevalence, deaths, and burden of various digestive diseases have risen significantly. Among these, MAFLD, including cirrhosis, showed the most dramatic increases, with a 500% increase in prevalence, a 345% rise in all-age deaths, and a 438% increase in DALYs. Alcohol and tobacco emerged as the two primary risk factors for higher DALYs for digestive diseases. Alcohol was strongly associated with higher DALYs for cirrhosis, while tobacco was linked to increased DALYs for gallbladder and biliary diseases, upper digestive system diseases, and peptic ulcers. Conclusion: Digestive diseases are increasingly prevalent in Jordan, with MAFLD leading the rise, reflecting better management and prevention. These contrasting trends highlight the need for optimized public health strategies to reduce morbidity and mortality, alongside further research to address the unique challenges posed by modern lifestyles and shifting dynamics in this region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.